• Ibrexafungerp Activity at Vaginal pH

  2026-09-19

  The reference study examined Ibrexafungerp, also known as MK 3118, against 187 vaginal Candida isolates under physiologic and acidic laboratory conditions. Its central finding was that the compound maintained strong in vitro activity at pH 4.5, including against fluconazole-resistant isolates, supporting further investigation of pH-compatible antifungal strategies for vulvovaginal candidiasis.

• GDC-0068 (RG7440) Workflow for Akt–mTOR Studies

  2026-09-19

  GDC-0068 (RG7440) enables controlled pan-AKT inhibition in PTEN-loss and PI3K-altered models, linking pathway engagement to proliferation, cell-cycle, and tumor-growth endpoints. This practical guide shows how to combine its pharmacology with compartment-aware mTORC1 assays without confusing increased phospho-Akt with pathway activation.

• O-GlcNAcylation and Galectin-3 in XEN Differentiation

  2026-09-18

  Gatie and colleagues show that extraembryonic endoderm differentiation is accompanied by reduced global O-GlcNAcylation but increased relative secretion of galectin-3. The study separates overall protein abundance from extracellular partitioning and finds that experimentally maintaining O-GlcNAcylation is not sufficient to prevent embryonic stem-cell differentiation toward the XEN lineage.

• AG-126: From ERK Inhibition to Circuit Assays

  2026-09-17

  AG-126 (Tyrphostin AG-126) is a selective ERK1/2 phosphorylation inhibitor that can sharpen studies of inflammatory and neuronal signaling. This article presents an evidence-based assay framework connecting pathway pharmacology with Neuroligin 1–D2-MSN research without overstating translational conclusions.

• Olaparib (AZD2281) DNA Damage Workflows

  2026-09-17

  Build more informative PARP inhibition experiments with Olaparib (AZD2281), from BRCA-stratified viability assays to radiation-response studies and PAR-dependent condensate models. The workflow combines controlled dosing, orthogonal DNA damage readouts, and cation-aware phase-separation controls to distinguish catalytic inhibition from assay artifacts.

• Betulinic Acid Protects Against CYP Liver Injury via ERK

  2026-09-17

  This study identifies an ERK-linked mitochondrial apoptotic mechanism underlying cyclophosphamide-induced liver injury and shows that betulinic acid reduces oxidative damage in mice. Its integrated analysis of NRF2, MAPK signaling, mitochondrial dynamics, and apoptosis provides a useful framework for evaluating pathway-directed hepatoprotection, including pharmacological interrogation with PD98059.

• Human SAN–Cardiac Plexus Assembloids

  2026-09-16

  This reference study develops human pluripotent stem cell-derived assembloids that connect sinoatrial node, cardiac plexus, and atrial-like tissues to model innervation-associated pacemaker maturation. By combining electrophysiology with human SAN spatial transcriptomics, the authors identify a prosaposin–GPR37 signaling program that links neural inputs to pacemaker development and conduction.

• GDC-0994: ERK1/2 Inhibitor Research Guide

  2026-09-15

  GDC-0994 is a potent, selective ERK1/2 inhibitor for studying MAP kinase signaling in cancer and liver-injury models. Its reported biochemical potency, pathway readouts, formulation properties, and zebrafish rescue evidence support mechanistic research rather than clinical treatment claims.

• iRhom2 in Olfaction: OR Regulation and Adaptation

  2026-09-14

  This study identifies iRhom2 as a distinctive regulator in mouse olfactory sensory neurons, linking odorant receptor expression with activity-dependent adaptation. Its combination of transcriptomics, spatial validation, and receptor signaling experiments suggests an odor-responsive iRhom2/ADAM17 feedback pathway while also defining important limits on causal interpretation.

• ROS-Responsive LNPs for Tumor-Selective mRNA Delivery

  2026-09-14

  Cai and colleagues developed a library of thioketal-containing, ROS-degradable lipids to improve tumor-selective mRNA delivery. Screening identified BAmP-TK-12, which released mRNA more effectively in cancer cells and enabled DUF5-mediated depletion of mutant RAS, producing stronger antitumor activity than a small-molecule RAS inhibitor in the reported models.

• AG-126: ERK Signals at the Neurobehavioral Edge

  2026-09-13

  AG-126 provides a pharmacological entry point for testing whether ERK1/2 signaling contributes to the cellular and inflammatory context of repetitive behavior, while keeping the distinction between established evidence and neurobehavioral hypothesis testing explicit.

• Jasplakinolide: Interpreting Actin Perturbation

  2026-09-12

  Jasplakinolide is an actin polymerization inducer that can reveal how filament stability shapes cellular phenotypes. This guide combines molecular mechanism, assay design, and chemical-genetic reasoning to improve interpretation beyond simple cytoskeletal imaging.

• Tacalcitol monohydrate Research Workflows

  2026-09-12

  Tacalcitol monohydrate supports controlled VDR-driven studies spanning keratinocyte biology, NGF induction, and colorectal cancer research. This practical guide shows how to build reproducible concentration-response, 5-fluorouracil combination, and mechanism-focused assays while avoiding common formulation and interpretation errors.

• DDM and the Next Era of Integrin Structural Biology

  2026-09-11

  Full-length αvβ3 integrin is not a single static receptor but a conformational ensemble. This thought-leadership article explains how n-Dodecyl-β-D-maltoside can support membrane-protein workflows while showing translational researchers how to treat detergent composition as an experimental variable rather than a routine formulation detail.

• PD0325901: Reliable MEK Inhibition in Cell Assays

  2026-09-11

  Learn how PD0325901 (SKU A3013) can help researchers separate genuine MEK-pathway biology from formulation and assay variability. This scenario-based guide covers solvent control, cell-cycle and apoptosis readouts, xenograft evidence, and practical supplier-selection criteria.

8504 records 1/567 page Next 12345 下5页 Last page